ARLINGTON, Va. — With American Pharmacists Month observed in October, and World Pharmacists Day observed on September 25, NACDS is distributing its 30-second message that reflects pharmacies’ and pharmacists’ commitment to serving as part of the solution to opioid abuse and to pain care. NACDS president and chief executive officer Steven Anderson said, “Opioid abuse
ARLINGTON, Va. — On a strong bipartisan basis, the chairman, ranking member, and an overwhelming majority of the Senate Finance Committee have asked the Trump Administration to do its part to close a Medicare regulation loophole – known as pharmacy direct and indirect remuneration (DIR) fees – that inflates patients’ out-of-pocket drug costs and that
BOSTON – “We have big issues. We have big ideas. So thank you for your role in addressing and advancing them at TSE.” With those words, National Association of Chain Drug Stores (NACDS) chairman of the board Chris Lane, executive vice president of Wakefern Food Corp./ShopRite, summarized the NACDS Total Store Expo’s role in helping
SANFORD, N.C. — DisposeRx, a drug disposal company committed to eradicating the misuse of leftover medications in the home medicine cabinet, announced Wednesday its support and affirmation of a statement recently issued by the National Association of Chain Drug Stores (NACDS) regarding the key role of community pharmacies in helping to solve the opioid crisis.
WASHINGTON – With the Senate Finance Committee holding a legislative markup today of the Prescription Drug Pricing Reduction Act (PDPRA) of 2019, eight associations noted initial bipartisan movement on direct and indirect remuneration (DIR) fee reform, but reiterated the need for swift and decisive action on this issue. Issuing a joint statement were: National Community
WASHINGTON — With the Senate Finance Committee expected to begin making decisions on spending bills as early as today, the National Association of Chain Drug Stores has launched a telephone hotline — (866) DIR-RE4M — that pharmacy advocates can use to urge the inclusion of DIR fee relief in drug-pricing legislation. An NACDS RxImpact grassroots
WASHINGTON — Ten NACDS board of directors members met with key members of Congress in Washington, D.C. this week. The meetings focused on conveying the urgent need for direct and indirect remuneration (DIR) fee relief. The timing was ideal, given that decisions are being made now about drug-pricing legislation.
ARLINGTON, Va. – Pharmacy “DIR fees” that have exploded by 45,000 percent from 2010 to 2017 are inflating seniors’ out-of-pocket costs for prescription drugs and forcing pharmacies out of business. These pharmacy “direct and indirect remuneration” (DIR) fees must be addressed in drug-pricing legislation. That message about DIR fees is the subject of a new cable, broadcast and
ARLINGTON, Va.— The National Association of Chain Drug Stores (NACDS) on Monday praised Missouri’s enactment of SB 514, which requires electronic prescriptions for controlled substances, with specified exceptions, effective January 1, 2021. The measure is vital for helping to address the opioid-abuse epidemic by reducing fraud and abuse. Missouri Gov. Mike Parson (R) signed the
Chain drug retailing has thus far largely escaped the repercussions of the opioid epidemic, an ongoing tragedy which has seen so many people become addicted to pharmaceutical products that, when taken as prescribed and properly managed, can bring needed relief to patients with serious illnesses or injuries. Several of America’s most prominent pharmaceutical houses have
ARLINGTON, Va. — NACDS Thursday praised Delaware’s enactment of HB 115, which requires podiatrists, dentists, doctors, nurses and optometrists who issue prescriptions to utilize electronic prescriptions except under certain exceptions. The measure is vital for helping to address the opioid-abuse epidemic by reducing fraud and abuse. Delaware Gov. John Carney (D) signed the bill today,
ARLINGTON, Va. — The bipartisanship of the John S. McCain Opioid Addiction Prevention Act (S. 724/H.R. 1614) is matched by its diverse support among addiction experts, pain management specialists, patient advocates and pharmacies, as indicated by a letter from 42 entities – and growing – to members of the U.S. Congress. American Society of Addiction